News & Insights
Featured
Article
08.13.2026
Managed Healthcare Executive: PBMI Innovator Patrick Gleason, Pharm.D.
Patrick Gleason, Pharm.D., of Prime Therapeutics was named a 2026 PBMI Innovator for his work on cost-effective formulary strategy and real-world evidence generation.
Article
07.30.2026
RealClearHealth: The Question We Should Be Asking About Drug Costs
Mostafa Kamal, chief executive officer at Prime Therapeutics, shares why the key question in the drug pricing debate is not just where health care value is created, but whether it ultimately reaches the patients, employers and health plans paying for care.
Library
Category
Topic
Type
Keyword search
Article
08.14.2026
Prime Therapeutics supports expanded prescription drug price transparency and consumer choice
Article
08.13.2026
Managed Healthcare Executive: PBMI Innovator Patrick Gleason, Pharm.D.
Login Portals
Compliance / Legal
Company
© 2026 Prime Therapeutics LLC
